Cargando…
Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C
We administered zinc supplementation therapy over three years to patients with chronic hepatitis C and reported and that the aspartate aminotransferase (AST) and alanine aminotaransferase (ALT) levels decreased, and platelet counts increased, significantly in the group with increased serum zinc conc...
Autores principales: | Matsumura, Hiroshi, Nirei, Kazushige, Nakamura, Hitomi, Arakawa, Yasuo, Higuchi, Teruhisa, Hayashi, Jyunpei, Yamagami, Hiroaki, Matsuoka, Syunichi, Ogawa, Masahiro, Nakajima, Noriko, Tanaka, Naohide, Moriyama, Mitsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491241/ https://www.ncbi.nlm.nih.gov/pubmed/23170044 http://dx.doi.org/10.3164/jcbn.12-11 |
Ejemplares similares
-
Zinc Supplementation Improves the Outcome of Chronic Hepatitis C and Liver Cirrhosis
por: Matsuoka, Shunichi, et al.
Publicado: (2009) -
Expression of Intercellular Adhesion Molecule-1 in the Livers of Rats Treated with Diethylnitrosamine
por: Matsuoka, Shunichi, et al.
Publicado: (2009) -
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017) -
Involvement of Ornithine Carbamoyltransferase in the Progression of Chronic Hepatitis C and Liver Cirrhosis
por: Ohnishi, Masahiko, et al.
Publicado: (2017) -
Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients
por: Nirei, Kazushige, et al.
Publicado: (2017)